Rangeley Capital’s Drugs Made In America Acquisition II Corp Unit DMIIU Stock Holding History

Rangeley Capital’s Portfolio DMIIU Stock Details DMIIU Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$327K	Buy	55,612 +23,061	+71%	+$232K	0.35%	67
2025 Q4	$326K	Buy	+32,551	New	+$326K	0.28%	70

Other funds holding DMIIU

LMR Partners London, United Kingdom $10.9B AUM 60.68% 1-Year Est. Return

Westchester Capital Management (New York) Valhalla, New York $2.07B AUM 26.02% 1-Year Est. Return

TIG Advisors LLC New York $2.09B AUM 72.99% 1-Year Est. Return

BlueCrest Capital Management St Helier, Jersey $1.06B AUM 20.01% 1-Year Est. Return

Verition Fund Management

Verition Fund Management Greenwich, Connecticut $10.3B AUM 30.69% 1-Year Est. Return

Kepos Capital New York $61.3M AUM 12.13% 1-Year Est. Return

Clear Street New York $17.8B AUM 56.26% 1-Year Est. Return

L1 Global Manager Melbourne $124M AUM

Readystate Asset Management Chicago, Illinois $1.71B AUM 15% 1-Year Est. Return

Walleye Capital

Walleye Capital New York $16.3B AUM 37.67% 1-Year Est. Return